By Professor Michael Proinsias Farrell

Journal articles

Hall W; Farrell M, 2021, 'What can we learn from the history of research on psychedelic drugs in the addictions?', Addiction, 116, pp. 2936 - 2938, http://dx.doi.org/10.1111/add.15560

Lewer D; Eastwood B; White M; Brothers TD; McCusker M; Copeland C; Farrell M; Petersen I, 2021, 'Fatal opioid overdoses during and shortly after hospital admissions in England: A casecrossover study', PLoS Medicine, 18, http://dx.doi.org/10.1371/journal.pmed.1003759

Bargeron L; Farrell M, 2021, 'The Price Effect of Stock Repurchases: Evidence from Dual Class Firms', MANAGEMENT SCIENCE, 67, http://dx.doi.org/10.1287/mnsc.2021.4066

Santo T; Clark B; Hickman M; Grebely J; Campbell G; Sordo L; Chen A; Tran LT; Bharat C; Padmanathan P; Cousins G; Dupouy J; Kelty E; Muga R; Nosyk B; Min J; Pavarin R; Farrell M; Degenhardt L, 2021, 'Association of Opioid Agonist Treatment with All-Cause Mortality and Specific Causes of Death among People with Opioid Dependence: A Systematic Review and Meta-analysis', JAMA Psychiatry, 78, pp. 979 - 993, http://dx.doi.org/10.1001/jamapsychiatry.2021.0976

Man N; Chrzanowska A; Price O; Bruno R; Dietze PM; Sisson SA; Degenhardt L; Salom C; Morris L; Farrell M; Peacock A, 2021, 'Trends in cocaine use, markets and harms in Australia, 2003–2019', Drug and Alcohol Review, 40, pp. 946 - 956, http://dx.doi.org/10.1111/dar.13252

Nielsen S; Gisev N; Leung J; Clare P; Bruno R; Lintzeris N; Larance B; Blyth F; Hall W; Cohen M; Degenhardt L; Farrell M; Campbell G, 2021, 'Clinical correlates and outcomes associated with pregabalin use among people prescribed opioids for chronic non-cancer pain: A five-year prospective cohort study', British Journal of Clinical Pharmacology, 87, pp. 3092 - 3104, http://dx.doi.org/10.1111/bcp.14715

Yuen WS; Chan G; Bruno R; Clare PJ; Aiken A; Mattick R; Farrell M; Kypri K; Slade T; Hutchinson D; McBride N; McCambridge J; Boland V; Peacock A; Peacock A, 2021, 'Trajectories of alcohol-induced blackouts in adolescence: early risk factors and alcohol use disorder outcomes in early adulthood', Addiction, 116, pp. 2039 - 2048, http://dx.doi.org/10.1111/add.15415

Courtney RJ; McRobbie H; Tutka P; Weaver NA; Petrie D; Mendelsohn CP; Shakeshaft A; Talukder S; Macdonald C; Thomas D; Kwan BCH; Walker N; Gartner C; Mattick RP; Paul C; Ferguson SG; Zwar NA; Richmond RL; Doran CM; Boland VC; Hall W; West R; Farrell M, 2021, 'Effect of Cytisine vs Varenicline on Smoking Cessation: A Randomized Clinical Trial', JAMA - Journal of the American Medical Association, 326, pp. 56 - 64, http://dx.doi.org/10.1001/jama.2021.7621

Huang H; Sequoia K; Yamaguchi M; Boehm KJ; Engelhorn K; Walker J; Elsner F; Tomlin J; Farrell M; Fontes CJ; Colgan JP, 2021, 'Improved x-ray mass attenuation coefficient (opacity) measurements for Fe, Ni and Au', Journal of Physics B: Atomic, Molecular and Optical Physics, 54, pp. 115003 - 115003, http://dx.doi.org/10.1088/1361-6455/abf01c

Nielsen S; Sanfilippo P; Belackova V; Day C; Silins E; Lintzeris N; Bruno R; Grebely J; Lancaster K; Ali R; Bell J; Dietze P; Degenhardt L; Farrell M; Larance B, 2021, 'Perceptions of injectable opioid agonist treatment (iOAT) among people who regularly use opioids in Australia: findings from a cross-sectional study in three Australian cities', Addiction, 116, pp. 1482 - 1494, http://dx.doi.org/10.1111/add.15297

Deacon RM; Mammen K; Bruno R; Mills L; Dunlop A; Holmes J; Jefferies M; Hall M; Shakeshaft A; Farrell M; Graham R; Lintzeris N, 2021, 'Assessing the concurrent validity, inter-rater reliability and test–re-test reliability of the Australian Treatment Outcomes Profile (ATOP) in alcohol and opioid treatment populations', Addiction, 116, pp. 1245 - 1255, http://dx.doi.org/10.1111/add.15331

Degenhardt L; Hungerford P; Nielsen S; Bruno R; Larance B; Clare PJ; Dobbins T; Hall W; Cohen M; Blyth F; Lintzeris N; Farrell M; Campbell G, 2021, 'Pharmaceutical Opioid Use Patterns and Indicators of Extramedical Use and Harm in Adults with Chronic Noncancer Pain, 2012-2018', JAMA Network Open, 4, http://dx.doi.org/10.1001/jamanetworkopen.2021.3059

McKetin R; Farrell M, 2021, 'When the evidence is not enough: is it time to rethink trial design?', Addiction, 116, pp. 711 - 712, http://dx.doi.org/10.1111/add.15273

Maher L; Harrod M; Farrell M; Wilson D, 2021, 'A Systematic Review of Interventions Used to Increase Blood Donor Compliance with Deferral Criteria', Transfusion Medicine and Hemotherapy, http://dx.doi.org/10.1159/000509027

Darke S; Duflou J; Farrell M; Peacock A; Lappin J; Peacock A, 2021, 'Characteristics and circumstances of death related to the self-administration of ketamine', Addiction, 116, pp. 339 - 345, http://dx.doi.org/10.1111/add.15154

Jones NR; Nielsen S; Farrell M; Ali R; Gill A; Larney S; Degenhardt L, 2021, 'Retention of opioid agonist treatment prescribers across New South Wales, Australia, 2001–2018: Implications for treatment systems and potential impact on client outcomes', Drug and Alcohol Dependence, 219, http://dx.doi.org/10.1016/j.drugalcdep.2020.108464

Darke S; Duflou J; Larance B; Farrell M; Lappin J, 2021, 'Characteristics and circumstances of death related to buprenorphine toxicity in Australia', Drug and Alcohol Dependence, 218, http://dx.doi.org/10.1016/j.drugalcdep.2020.108360

Wang Y; Liu M; Lu Q; Farrell M; Lappin JM; Shi J; Lu L; Bao Y, 2020, 'Global prevalence and burden of HIV-associated neurocognitive disorder: A meta-analysis', Neurology, 95, pp. E2610 - E2621, http://dx.doi.org/10.1212/WNL.0000000000010752

Darke S; Peacock A; Duflou J; Farrell M; Lappin J; Peacock A, 2020, 'Characteristics and circumstances of death related to gamma hydroxybutyrate (GHB)', Clinical Toxicology, 58, pp. 1028 - 1033, http://dx.doi.org/10.1080/15563650.2020.1726378

Campbell G; Noghrehchi F; Nielsen S; Clare P; Bruno R; Lintzeris N; Cohen M; Blyth F; Hall W; Larance B; Hungerford P; Dobbins T; Farrell M; Degenhardt L, 2020, 'Risk factors for indicators of opioid-related harms amongst people living with chronic non-cancer pain: Findings from a 5-year prospective cohort study', EClinicalMedicine, 28, http://dx.doi.org/10.1016/j.eclinm.2020.100592

McKetin R; Boden JM; Foulds JA; Najman JM; Ali R; Degenhardt L; Baker AL; Ross J; Farrell M; Weatherburn D, 2020, 'The contribution of methamphetamine use to crime: Evidence from Australian longitudinal data', Drug and Alcohol Dependence, 216, pp. 108262, http://dx.doi.org/10.1016/j.drugalcdep.2020.108262

Cepeda JA; Vickerman P; Bruneau J; Zang G; Borquez A; Farrell M; Degenhardt L; Martin NK, 2020, 'Estimating the contribution of stimulant injection to HIV and HCV epidemics among people who inject drugs and implications for harm reduction: A modeling analysis', Drug and Alcohol Dependence, 213, http://dx.doi.org/10.1016/j.drugalcdep.2020.108135

Campbell G; Darke S; Degenhardt L; Townsend H; Carter G; Draper B; Farrell M; Duflou J; Lappin J, 2020, 'Prevalence and Characteristics Associated with Chronic Noncancer Pain in Suicide Decedents: A National Study', Suicide and Life-Threatening Behavior, 50, pp. 778 - 791, http://dx.doi.org/10.1111/sltb.12627

Larance B; Byrne M; Lintzeris N; Nielsen S; Grebely J; Degenhardt L; Shahbazi J; Shanahan M; Lancaster K; Dore G; Ali R; Farrell M; Treloar C, 2020, 'Open-label, multicentre, single-arm trial of monthly injections of depot buprenorphine in people with opioid dependence: Protocol for the CoLAB study', BMJ Open, 10, pp. e034389, http://dx.doi.org/10.1136/bmjopen-2019-034389

Guillaumier A; Skelton E; Shakeshaft A; Farrell M; Tzelepis F; Walsberger S; D'Este C; Paul C; Dunlop A; Stirling R; Fowlie C; Kelly P; Oldmeadow C; Palazzi K; Bonevski B, 2020, 'Effect of increasing the delivery of smoking cessation care in alcohol and other drug treatment centres: a cluster-randomized controlled trial', Addiction, 115, pp. 1345 - 1355, http://dx.doi.org/10.1111/add.14911

Larance B; Degenhardt L; Grebely J; Nielsen S; Bruno R; Dietze P; Lancaster K; Larney S; Santo T; Shanahan M; Memedovic S; Ali R; Farrell M, 2020, 'Perceptions of extended-release buprenorphine injections for opioid use disorder among people who regularly use opioids in Australia', Addiction, 115, pp. 1295 - 1305, http://dx.doi.org/10.1111/add.14941

Bórquez A; Rich K; Farrell M; Degenhardt L; McKetin R; Tran LT; Cepeda J; Silva-Santisteban A; Konda K; Cáceres CF; Kelly S; Altice FL; Martin NK, 2020, 'Integrating HIV pre-exposure prophylaxis and harm reduction among men who have sex with men and transgender women to address intersecting harms associated with stimulant use: a modelling study', Journal of the International AIDS Society, 23, http://dx.doi.org/10.1002/jia2.25495

Darke S; Duflou J; Farrell M; Peacock A; Lappin J, 2020, 'Characteristics and circumstances of synthetic cannabinoid-related death', Clinical Toxicology, 58, pp. 368 - 374, http://dx.doi.org/10.1080/15563650.2019.1647344

Quinn B; Pearson R; Cutts J; Seed C; Scott N; Hoad V; Dietze P; Wilson D; Maher L; Thompson A; Farrell M; Harrod M; Caris S; Pink J; Kotsiou G; Hellard M, 2020, 'Blood donation amongst people who inject drugs in Australia: research supporting policy change', Vox Sanguinis, 115, pp. 162 - 170, http://dx.doi.org/10.1111/vox.12891

Farrell M; Robertson R, 2020, 'Commentary on Ho et al. (2020): Managing people with HIV and drug problems is complex and multi-faceted', Addiction, 115, pp. 653 - 654, http://dx.doi.org/10.1111/add.14950

Black N; Campbell G; Tran LT; Farrell M; Hall W; Degenhardt L, 2020, 'Cannabinoids for the treatment of mental disorders – Author's reply', The Lancet Psychiatry, 7, pp. 127 - 128, http://dx.doi.org/10.1016/S2215-0366(19)30526-7

Colledge S; Larney S; Peacock A; Leung J; Hickman M; Grebely J; Farrell M; Degenhardt L, 2020, 'Depression, post-traumatic stress disorder, suicidality and self-harm among people who inject drugs: A systematic review and meta-analysis', Drug and Alcohol Dependence, 207, http://dx.doi.org/10.1016/j.drugalcdep.2019.107793

Farrell M; Clarke G; Barr G; Hannon J, 2020, 'Monitoring of prenatal patients using a combined antibody titre for Rh and non-Rh antibodies', TRANSFUSION MEDICINE, 30, pp. 210 - 214, http://dx.doi.org/10.1111/tme.12661

Jacka B; Larance B; Copeland J; Burns L; Farrell M; Jackson E; Degenhardt L, 2020, 'Health care engagement behaviors of men who use performance- and image-enhancing drugs in Australia', Substance Abuse, 41, pp. 139 - 145, http://dx.doi.org/10.1080/08897077.2019.1635954

Nielsen S; Picco L; Campbell G; Lintzeris N; Larance B; Farrell M; Degenhardt L; Bruno R, 2020, 'Development of a brief patient-administered screening tool for prescription opioid dependence for primary care settings', Pain Medicine (United States), 21, pp. E79 - E88, http://dx.doi.org/10.1093/pm/pnz213

Peacock A; Gisev N; Memedovic S; Larance B; Brown J; Cairns R; Buckley N; Farrell M; Degenhardt L, 2020, 'Opioid use and harms associated with a sustained-release tapentadol formulation: A post-marketing surveillance study.', Drug Alcohol Depend, 206, pp. 107697, http://dx.doi.org/10.1016/j.drugalcdep.2019.107697

Fischer B; Daldegan-Bueno D; Bell R; Boden JM; Bullen C; Farrell M; Hall W; Newcombe D, 2020, 'The Lower-Risk Cannabis Use Guidelines (LRCUG): A ready-made targeted prevention tool for cannabis in New Zealand.', Public Health Pract (Oxf), 1, pp. 100046, http://dx.doi.org/10.1016/j.puhip.2020.100046

Suerink M; Rodríguez-Girondo M; van der Klift HM; Colas C; Brugieres L; Lavoine N; Jongmans M; Munar GC; Evans DG; Farrell MP; Genuardi M; Goldberg Y; Gomez-Garcia E; Heinimann K; Hoell JI; Aretz S; Jasperson KW; Kedar I; Modi MB; Nikolaev S; van Os TAM; Ripperger T; Rueda D; Senter L; Sjursen W; Sunde L; Therkildsen C; Tibiletti MG; Trainer AH; Vos YJ; Wagner A; Winship I; Wimmer K; Zimmermann SY; Vasen HF; van Asperen CJ; Houwing-Duistermaat JJ; ten Broeke SW; Nielsen M, 2019, 'An alternative approach to establishing unbiased colorectal cancer risk estimation in Lynch syndrome', Genetics in Medicine, 21, pp. 2706 - 2712, http://dx.doi.org/10.1038/s41436-019-0577-z

Gisev N; Nielsen S; Campbell G; Santo T; Mant A; Bruno R; Cohen M; Hall WD; Larance B; Lintzeris N; Farrell M; Degenhardt L, 2019, 'Antidepressant Use among People Prescribed Opioids for Chronic Noncancer Pain', Pain Medicine (United States), 20, pp. 2450 - 2458, http://dx.doi.org/10.1093/pm/pnz009

Black N; Stockings E; Campbell G; Tran LT; Zagic D; Hall WD; Farrell M; Degenhardt L, 2019, 'Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analysis', The Lancet Psychiatry, 6, pp. 995 - 1010, http://dx.doi.org/10.1016/S2215-0366(19)30401-8

Ma J; Bao YP; Wang RJ; Su MF; Liu MX; Li JQ; Degenhardt L; Farrell M; Blow FC; Ilgen M; Shi J; Lu L, 2019, 'Effects of medication-assisted treatment on mortality among opioids users: a systematic review and meta-analysis', Molecular Psychiatry, 24, pp. 1868 - 1883, http://dx.doi.org/10.1038/s41380-018-0094-5

Peacock A; Bruno R; Gisev N; Degenhardt L; Hall W; Sedefov R; White J; Thomas KV; Farrell M; Griffiths P, 2019, 'New psychoactive substances: challenges for drug surveillance, control, and public health responses', The Lancet, 394, pp. 1668 - 1684, http://dx.doi.org/10.1016/S0140-6736(19)32231-7

Farrell M; Martin NK; Stockings E; Bórquez A; Cepeda JA; Degenhardt L; Ali R; Tran LT; Rehm J; Torrens M; Shoptaw S; McKetin R, 2019, 'Responding to global stimulant use: challenges and opportunities', The Lancet, 394, pp. 1652 - 1667, http://dx.doi.org/10.1016/S0140-6736(19)32230-5

Darke S; Duflou J; Peacock A; Farrell M; Lappin J, 2019, 'Characteristics and circumstances of death related to new psychoactive stimulants and hallucinogens in Australia', Drug and Alcohol Dependence, 204, http://dx.doi.org/10.1016/j.drugalcdep.2019.107556

Darke S; Farrell M; Duflou J; Larance B; Lappin J, 2019, 'Circumstances of death of opioid users being treated with naltrexone', Addiction, 114, pp. 2000 - 2007, http://dx.doi.org/10.1111/add.14729

Clarke N; Vale G; Reeves EP; Kirwan M; Smith D; Farrell M; Hurl G; McElvaney NG, 2019, 'GDPR: an impediment to research?', IRISH JOURNAL OF MEDICAL SCIENCE, 188, pp. 1129 - 1135, http://dx.doi.org/10.1007/s11845-019-01980-2

McKetin R; Leung J; Stockings E; Huo Y; Foulds J; Lappin JM; Cumming C; Arunogiri S; Young JT; Sara G; Farrell M; Degenhardt L, 2019, 'Mental health outcomes associated with of the use of amphetamines: A systematic review and meta-analysis', EClinicalMedicine, 16, pp. 81 - 97, http://dx.doi.org/10.1016/j.eclinm.2019.09.014

Degenhardt L; Wolfe D; Hall W; Hickman M; Chang J; Bruneau J; Farrell M; Griffiths P, 2019, 'Strategies to reduce drug-related harm: responding to the evidence base', The Lancet, 394, pp. 1490 - 1493, http://dx.doi.org/10.1016/S0140-6736(19)32232-9

Stockings E; Tran LT; Santo T; Peacock A; Larney S; Santomauro D; Farrell M; Degenhardt L, 2019, 'Mortality among people with regular or problematic use of amphetamines: a systematic review and meta-analysis', Addiction, 114, pp. 1738 - 1750, http://dx.doi.org/10.1111/add.14706

Farrell MP; Yi CC, 2019, 'Sociological Perspectives on Contemporary Taiwanese Families', Journal of Family Issues, 40, pp. 1887 - 1895, http://dx.doi.org/10.1177/0192513X19863195

Back to profile page